Dogwood Therapeutics, Inc. (DWTX) Operating income 2020–2025
Dogwood Therapeutics, Inc. (DWTX) annual operating income history from SEC filings — each fiscal year as reported.
-$28.0MFY2025 · since FY2020: -$10.0M → -$28.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.0M | -128.7% |
| FY2024 | -$12.2M | -124.5% |
| FY2023 | -$5.4M | +55.8% |
| FY2022 | -$12.3M | +21.3% |
| FY2021 | -$15.6M | -56.3% |
| FY2020 | -$10.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DWTX financial trends
DWTX RevenueDWTX Net incomeDWTX Net marginDWTX Gross profitDWTX Gross marginDWTX Operating marginDWTX Operating cash flowDWTX Free cash flowDWTX Capital expendituresDWTX Return on equityDWTX Stock buybacksDWTX Dividends paidDWTX Total assetsDWTX Total liabilitiesDWTX Shareholders’ equityDWTX overview →